The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.
about
Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC)Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy.Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture.Capturing drug responses by quantitative promoter activity profiling.The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.Determination of the Proteomic Response to Lapatinib Treatment using a comprehensive and reproducible ion-current-based proteomics strategy.Development of a label-free LC-MS/MS strategy to approach the identification of candidate protein biomarkers of disease recurrence in prostate cancer patients in a clinical trial of combined hormone and radiation therapy.Investigations on the cell metabolomics basis of multidrug resistance from tumor cells by ultra-performance liquid chromatography-mass spectrometry.
P2860
Q28487758-D7800E4F-5E20-4D5A-87FB-5B8ABA448F75Q37657753-0D1378F4-0EE7-494E-A62D-FDBCF0156D12Q38824059-1F600753-3C2F-4069-A7E7-DE3D2CDC4413Q38949883-4E8991DC-0D89-4335-9475-9DCAA79368E5Q39033586-3E2AFFDF-5594-49AA-BEBC-B993BBFFDE62Q39468169-C142DDEA-925D-490B-BBD3-AC8C7670AD37Q39756394-2E2B533D-BF65-42B9-BFAC-79CC2AB57CDFQ41127809-351B20E7-79A5-4B04-8C4F-65EA69F29867Q42378682-B9A1F0C2-26EC-4A49-ACD5-9349FB0A3D90Q50996571-6918A6F1-E3DF-4420-A10A-4F704FF8D677Q51662791-33DCF068-3CD2-49B9-87FD-8DE4249A984A
P2860
The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@en
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@nl
type
label
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@en
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@nl
prefLabel
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@en
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@nl
P2093
P2860
P50
P356
P1433
P1476
The use of LC-MS to identify d ...... nt prostate cancer cell lines.
@en
P2093
Amanda O'Neill
Claire Corcoran
Michael Henry
Paula Meleady
William Watson
P2860
P304
P356
10.1002/PMIC.201100489
P577
2012-07-01T00:00:00Z